Health TrialsbyHealthPanel

Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Municipalities

ConditionSchool Attendance Problems
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-15
SponsorNorwegian University of Science and Technology

About this trial

In this study we will investigate the effects of an intervention called Back2School, revised and adapted for Norwegian conditions on school attendance. A total of 240 participants will be recruited. All participants who have been enrolled will receive the intervention. Half of the participants will receive the intervention without delay (the experiment group), and the other half will receive it following a 13-week period (the control group). Following consent, screening for eligibility and randomization, the intervention will start with an assessment related to the individual participant and condition at the participants' school. Based on this a shared understanding and an intervention plan is developed. Over a 13-week period the youth, the family and the school, work together guided by the municipal team to increase attendance and solve problems related to this. Assessments will be carried out after the intervention and 6 months later.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants must be between the ages of 9 and 15 at the time of enrollment.

Participants must have less than 80% attendance for the last 12 weeks of school at the time of screening.

At least one parent has to talk and understand Norwegian.

At least one parent has to be motivated to participate.

Disqualifiers

None

Trial design

Design model

Crossover

Treatments tested in this trial

  • Back2School

    Behavioral

    The revised Back2S school manual consists of an initial assessment, a case formulation conference, 16 sessions and 3 meetings with different participants (parents, youth, school personnel) over 13 weeks. There is a booster session 12 weeks after the final session and one 24 weeks after the final session.

Treatment groups

240 Participants
are divided into 2 treatment groups
Group A: Direct interventionExperimental treatment 1 intervention
Group B: Delayed intervention/ Wait list controlOther 1 intervention

Trial outcomes

Primary outcomes

1

School attendance

School attendance measured on a daily basis by teacher.

Time frame
Direct: Avg at Baseline, 2 weeks at end (13 weeks from baseline), 2 weeks at 6 months (37 w from baseline) Delayed: Avg at baseline, 2 weeks before start (13 w from baseline) 2 weeks at end (28 w from baseline), 2 weeks at 6 months (54 w from baseline)
2

General functioning

Impact on daily life as measured by the SDQ impact scale

Time frame
Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)

Secondary outcomes

1

Change in Quality of life

Measures perceived quality of life as reported by parents and child using Kidscreen 10

Time frame
Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)
2

Change in symptoms of anxiety

Measures change in symptoms of anxiety as measured by the SCAS reported by parents and child

Time frame
Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)
3

Change in symptoms of Depression

Change in symptoms of depression reported by child and parents using the SMFQ

Time frame
Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Norwegian University of Science and Technology

Lead sponsor

The Research Council of Norway

Collaborator

University of Tromso

Collaborator

University of Bergen

Collaborator

Regionsenter for barn og unges psykiske helse

Collaborator

Regionalt kunnskapssenter for barn og unge - Nord

Collaborator

NORCE Norwegian Research Centre AS

Collaborator

University of Stavanger

Collaborator

University of Aarhus

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: